Clinical Trials Blog

January 2025 clinical trial highlights

by Pulmonary Fibrosis Foundation
January 29, 2025

In the January 2025 clinical trial highlights, we'll showcase just a few of the many trials that are open for enrollment and seeking volunteers. To view more available trials for various forms of interstitial lung disease, please visit the 🔍 PFF Clinical Trial Finder this link will open a new tab..


Seeking participants with progressive pulmonary fibrosis

MIST

Learn more about this study this link will open a new tab.

Learn more about this drug this link will open a new tab.

 

Seeking participants with idiopathic pulmonary fibrosis

ALOFT-IPF

  • Study ID: NCT06003426
  • Trial Phase: Phase 3
  • Intervention: Oral drug
  • Sponsor: Bristol-Myers Squibb
  • Study Contact: Clinical.Trials@bms.com

Learn more about this study this link will open a new tab.

Learn more about this drug this link will open a new tab.

 

Seeking participants with progressive pulmonary fibrosis

ALOFT-PPF

  • Study ID: NCT06025578
  • Trial Phase: Phase 3
  • Intervention: Oral drug
  • Sponsor: Bristol-Myers Squibb
  • Study Contact: Clinical.Trials@bms.com

Learn more about this study this link will open a new tab.

Learn more about this drug this link will open a new tab.

Seeking participants with idiopathic pulmonary fibrosis

TRANSFORM

  • Study ID: NCT06317285
  • Trial Phase: Phase 2
  • Intervention: Oral drug
  • Sponsor: GlaxoSmithKline
  • Study Contact: 877.379.3718, GSKClinicalSupportHD@gsk.com

Learn more about this study this link will open a new tab.

Learn more about this drug this link will open a new tab.

Seeking participants with interstitial lung disease associated with connective tissue disease

BEconneCTD-ILD

  • Study ID: NCT06572384
  • Trial Phase: Phase 3
  • Intervention: Subcutaneous injection
  • Sponsor: GlaxoSmithKline
  • Study Contact: 877.379.3718, GSKClinicalSupportHD@gsk.com

Learn more about this study this link will open a new tab.

Learn more about this drug this link will open a new tab.

Research spotlight

To learn more about the five clinical trials featured in this newsletter, watch the Clinical Trial Innovation Series session hosted on Thursday, November 7, 2024 this link will open a new tab., during the 2024 PFF Education Symposium. You will hear directly from the industry representatives running these research studies.

The purpose of the Clinical Trial Innovation Series is to provide up-to-date information about the development of innovative therapies and advancements in research to improve the lives of those living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).